About
About Optiscan Imaging Limited
Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Visit company website
5 years, 5 months ago
Optiscan Imaging Limited is currently in a long term uptrend where the price is trading 14.6% above its 200 day moving average.
From a valuation standpoint, the stock is 14.8% more expensive than other stocks from the Technology sector with a price to sales ratio of 82.0.
Optiscan Imaging Limited's total revenue rose by 60.4% to $534K since the same quarter in the previous year.
Its net income has increased by 37.5% to $-752K since the same quarter in the previous year.
Finally, its free cash flow grew by 81.9% to $-91K since the same quarter in the previous year.
Based on the above factors, Optiscan Imaging Limited gets an overall score of 4/5.